Project Grant T32CA299000
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $403K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
- The National Cancer Institute awarded the University of Southern California $254,091 on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support postdoctoral training in integrative cancer epidemiology. The award funds a joint training program administered by USC's Norris Comprehensive Cancer Center and the University of Hawaii Cancer Center. The program trains postdoctoral fellows for independent careers in integrative cancer epidemiology research, emphasizing...
- The National Cancer Institute awarded The Washington University $637,394 on August 5, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop positron emission tomography imaging using a radiotracer (64Cu-DOTA-ECL1I) that quantifies C-C motif chemokine receptor 2 (CCR2) expression in head and neck squamous cell carcinoma patients. The project will establish CCR2-PET as a prognostic biomarker to predict tumor activity, disease recurrence, and response to...
- The National Cancer Institute awarded The Washington University $882,444 on September 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to test clarified imaging reports designed to reduce anxiety, fear of cancer recurrence, and improve understanding of follow-up care needs among adult survivors of pediatric brain cancer. The research comprises three aims. Aim 1 will explore through interviews how adult survivors of pediatric brain cancer and their care teams prefer...
- The National Cancer Institute awarded The Washington University $399,829 on May 13, 2026, under the Cancer Treatment Research program (CFDA 93.395) to mechanistically characterize a novel dendritic cell-based immunotherapy for solid tumors. The project will investigate how engineered dendritic cells expressing a B7H3-specific chimeric antigen receptor fused to toll-like receptor 4 signaling domains can overcome tumor immune tolerance by efficiently capturing tumor antigens and cross-priming...
- The National Cancer Institute awarded The Washington University $645,414 on June 18, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop integrin-targeted positron emission tomography imaging and therapeutics for predicting and treating radiation-induced pulmonary fibrosis in lung cancer patients. The project uses mouse models of radiation-induced pulmonary fibrosis to test two complementary approaches: non-invasive αvβ6 PET imaging to detect early...
- The National Cancer Institute awarded $194,909 to the University of Florida on September 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and deliver the T-CAT (Trainees Communicating About Trials) Program, which trains physician trainees to communicate with patients about cancer clinical trials across the cancer continuum. The program addresses documented barriers to cancer clinical trial accrual, which remains at approximately 7–8 percent of cancer patients, with...
- The National Cancer Institute awarded The University of Iowa $563,887 on July 9, 2026, under the Cancer Research Manpower program (CFDA 93.398) to support a surgical oncology research training program. The University of Iowa will train surgeon-scientists through a two-year program maintaining three training slots per year. Trainees are MD or MD, PhD postgraduates who have completed at least two years of surgical residency and will pursue either basic science or clinical research tracks. The...
- The National Cancer Institute awarded Wake Forest University Health Sciences $323,623 on June 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to deliver the Qualitative Training Institute for Enhancing Cancer Research (CANCERQTI), a six-month hybrid skills development program addressing qualitative research methods in oncology. CANCERQTI recruits and enrolls 25 oncology researchers annually into a curriculum grounded in Kolb's experiential learning theory, designed to build...
- The National Cancer Institute awarded The Washington University $623,616 on July 10, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to support development of PET imaging methods for detecting and quantifying CD163+ tumor-associated macrophages in head and neck cancer. The research addresses the role of tumor-associated macrophages (TAMs) in the tumor microenvironment, which coordinate angiogenesis, extracellular matrix remodeling, cancer cell proliferation,...
- The National Cancer Institute awarded the Regents of the University of Minnesota $309,761 on May 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to develop and deliver a hands-on training course in biomarker development and applications for cancer prevention research. The course combines virtual modules on chemical carcinogenesis fundamentals with five weeks of in-person laboratory training in state-of-the-art biomarker measurement techniques at the Masonic Cancer Center....